Global Oncology Molecular Diagnostics Market 2023-2027

Report
174 Pages
July 2023
Region: Global
TechNavio
ID: 5868431

The oncology molecular diagnostics market is forecasted to grow by USD 2,980.87 mn during 2022-2027, accelerating at a CAGR of 11.82% during the forecast period. The report on the oncology molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer worldwide, growing geriatric population, and increase in adoption of microarrays in genomics and proteomics.

The oncology molecular diagnostics market is segmented as below:

By Product

Reagents and kits
Instruments

By Type

Breast cancer
Colorectal cancer
Prostate cancer
Liver cancer and others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the integration of next-generation sequencing in oncology molecular diagnostics as one of the prime reasons driving the oncology molecular diagnostics market growth during the next few years. Also, adoption of various collaboration strategies and increasing focus on emerging countries for cancer diagnosis and treatment will lead to sizable demand in the market.

The report on the oncology molecular diagnostics market covers the following areas:

Oncology molecular diagnostics market sizing
Oncology molecular diagnostics market forecast
Oncology molecular diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology molecular diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., MDXHEALTH SA, Myriad Genetics Inc., QIAGEN NV, QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., TBG Diagnostics Ltd., Thermo Fisher Scientific Inc., and Veracyte Inc.. Also, the oncology molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global oncology molecular diagnostics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global oncology molecular diagnostics market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Reagents and kits - Market size and forecast 2022-2027
Exhibit 34: Chart on Reagents and kits - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Reagents and kits - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Reagents and kits - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Reagents and kits - Year-over-year growth 2022-2027 (%)
6.4 Instruments - Market size and forecast 2022-2027
Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 44: Chart on Type - Market share 2022-2027 (%)
Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Breast cancer - Market size and forecast 2022-2027
Exhibit 48: Chart on Breast cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Breast cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Breast cancer - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Breast cancer - Year-over-year growth 2022-2027 (%)
7.4 Colorectal cancer - Market size and forecast 2022-2027
Exhibit 52: Chart on Colorectal cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Colorectal cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Colorectal cancer - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Colorectal cancer - Year-over-year growth 2022-2027 (%)
7.5 Prostate cancer - Market size and forecast 2022-2027
Exhibit 56: Chart on Prostate cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Prostate cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Prostate cancer - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Prostate cancer - Year-over-year growth 2022-2027 (%)
7.6 Liver cancer and others - Market size and forecast 2022-2027
Exhibit 60: Chart on Liver cancer and others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Liver cancer and others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Liver cancer and others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Liver cancer and others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Type
Exhibit 64: Market opportunity by Type ($ million)
Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 Agilent Technologies Inc.
Exhibit 120: Agilent Technologies Inc. - Overview
Exhibit 121: Agilent Technologies Inc. - Business segments
Exhibit 122: Agilent Technologies Inc. - Key offerings
Exhibit 123: Agilent Technologies Inc. - Segment focus
12.5 bioMerieux SA
Exhibit 124: bioMerieux SA - Overview
Exhibit 125: bioMerieux SA - Product/Service
Exhibit 126: bioMerieux SA - Key offerings
12.6 Danaher Corp.
Exhibit 127: Danaher Corp. - Overview
Exhibit 128: Danaher Corp. - Business segments
Exhibit 129: Danaher Corp. - Key news
Exhibit 130: Danaher Corp. - Key offerings
Exhibit 131: Danaher Corp. - Segment focus
12.7 F. Hoffmann La Roche Ltd.
Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Hologic Inc.
Exhibit 137: Hologic Inc. - Overview
Exhibit 138: Hologic Inc. - Business segments
Exhibit 139: Hologic Inc. - Key news
Exhibit 140: Hologic Inc. - Key offerings
Exhibit 141: Hologic Inc. - Segment focus
12.9 HTG Molecular Diagnostics Inc.
Exhibit 142: HTG Molecular Diagnostics Inc. - Overview
Exhibit 143: HTG Molecular Diagnostics Inc. - Product/Service
Exhibit 144: HTG Molecular Diagnostics Inc. - Key offerings
12.10 Illumina Inc.
Exhibit 145: Illumina Inc. - Overview
Exhibit 146: Illumina Inc. - Business segments
Exhibit 147: Illumina Inc. - Key news
Exhibit 148: Illumina Inc. - Key offerings
Exhibit 149: Illumina Inc. - Segment focus
12.11 Myriad Genetics Inc.
Exhibit 150: Myriad Genetics Inc. - Overview
Exhibit 151: Myriad Genetics Inc. - Product/Service
Exhibit 152: Myriad Genetics Inc. - Key offerings
12.12 QIAGEN NV
Exhibit 153: QIAGEN NV - Overview
Exhibit 154: QIAGEN NV - Product/Service
Exhibit 155: QIAGEN NV - Key news
Exhibit 156: QIAGEN NV - Key offerings
12.13 Siemens Healthineers AG
Exhibit 157: Siemens Healthineers AG - Overview
Exhibit 158: Siemens Healthineers AG - Business segments
Exhibit 159: Siemens Healthineers AG - Key news
Exhibit 160: Siemens Healthineers AG - Key offerings
Exhibit 161: Siemens Healthineers AG - Segment focus
12.14 Sysmex Corp.
Exhibit 162: Sysmex Corp. - Overview
Exhibit 163: Sysmex Corp. - Business segments
Exhibit 164: Sysmex Corp. - Key offerings
Exhibit 165: Sysmex Corp. - Segment focus
12.15 TBG Diagnostics Ltd.
Exhibit 166: TBG Diagnostics Ltd. - Overview
Exhibit 167: TBG Diagnostics Ltd. - Product/Service
Exhibit 168: TBG Diagnostics Ltd. - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 169: Thermo Fisher Scientific Inc. - Overview
Exhibit 170: Thermo Fisher Scientific Inc. - Business segments
Exhibit 171: Thermo Fisher Scientific Inc. - Key news
Exhibit 172: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 173: Thermo Fisher Scientific Inc. - Segment focus
12.17 Veracyte Inc.
Exhibit 174: Veracyte Inc. - Overview
Exhibit 175: Veracyte Inc. - Product/Service
Exhibit 176: Veracyte Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global oncology molecular diagnostics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Reagents and kits - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Reagents and kits - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Reagents and kits - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Reagents and kits - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Product ($ million)
Exhibits 43: Data Table on Market opportunity by Product ($ million)
Exhibits 44: Chart on Type - Market share 2022-2027 (%)
Exhibits 45: Data Table on Type - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Type
Exhibits 47: Data Table on Comparison by Type
Exhibits 48: Chart on Breast cancer - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Breast cancer - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Breast cancer - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Breast cancer - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Colorectal cancer - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Colorectal cancer - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Colorectal cancer - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Colorectal cancer - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Prostate cancer - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Prostate cancer - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Prostate cancer - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Prostate cancer - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Liver cancer and others - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Liver cancer and others - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Liver cancer and others - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Liver cancer and others - Year-over-year growth 2022-2027 (%)
Exhibits 64: Market opportunity by Type ($ million)
Exhibits 65: Data Table on Market opportunity by Type ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2022 and 2027
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Abbott Laboratories - Overview
Exhibits 116: Abbott Laboratories - Business segments
Exhibits 117: Abbott Laboratories - Key news
Exhibits 118: Abbott Laboratories - Key offerings
Exhibits 119: Abbott Laboratories - Segment focus
Exhibits 120: Agilent Technologies Inc. - Overview
Exhibits 121: Agilent Technologies Inc. - Business segments
Exhibits 122: Agilent Technologies Inc. - Key offerings
Exhibits 123: Agilent Technologies Inc. - Segment focus
Exhibits 124: bioMerieux SA - Overview
Exhibits 125: bioMerieux SA - Product/Service
Exhibits 126: bioMerieux SA - Key offerings
Exhibits 127: Danaher Corp. - Overview
Exhibits 128: Danaher Corp. - Business segments
Exhibits 129: Danaher Corp. - Key news
Exhibits 130: Danaher Corp. - Key offerings
Exhibits 131: Danaher Corp. - Segment focus
Exhibits 132: F. Hoffmann La Roche Ltd. - Overview
Exhibits 133: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 134: F. Hoffmann La Roche Ltd. - Key news
Exhibits 135: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 136: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 137: Hologic Inc. - Overview
Exhibits 138: Hologic Inc. - Business segments
Exhibits 139: Hologic Inc. - Key news
Exhibits 140: Hologic Inc. - Key offerings
Exhibits 141: Hologic Inc. - Segment focus
Exhibits 142: HTG Molecular Diagnostics Inc. - Overview
Exhibits 143: HTG Molecular Diagnostics Inc. - Product/Service
Exhibits 144: HTG Molecular Diagnostics Inc. - Key offerings
Exhibits 145: Illumina Inc. - Overview
Exhibits 146: Illumina Inc. - Business segments
Exhibits 147: Illumina Inc. - Key news
Exhibits 148: Illumina Inc. - Key offerings
Exhibits 149: Illumina Inc. - Segment focus
Exhibits 150: Myriad Genetics Inc. - Overview
Exhibits 151: Myriad Genetics Inc. - Product/Service
Exhibits 152: Myriad Genetics Inc. - Key offerings
Exhibits 153: QIAGEN NV - Overview
Exhibits 154: QIAGEN NV - Product/Service
Exhibits 155: QIAGEN NV - Key news
Exhibits 156: QIAGEN NV - Key offerings
Exhibits 157: Siemens Healthineers AG - Overview
Exhibits 158: Siemens Healthineers AG - Business segments
Exhibits 159: Siemens Healthineers AG - Key news
Exhibits 160: Siemens Healthineers AG - Key offerings
Exhibits 161: Siemens Healthineers AG - Segment focus
Exhibits 162: Sysmex Corp. - Overview
Exhibits 163: Sysmex Corp. - Business segments
Exhibits 164: Sysmex Corp. - Key offerings
Exhibits 165: Sysmex Corp. - Segment focus
Exhibits 166: TBG Diagnostics Ltd. - Overview
Exhibits 167: TBG Diagnostics Ltd. - Product/Service
Exhibits 168: TBG Diagnostics Ltd. - Key offerings
Exhibits 169: Thermo Fisher Scientific Inc. - Overview
Exhibits 170: Thermo Fisher Scientific Inc. - Business segments
Exhibits 171: Thermo Fisher Scientific Inc. - Key news
Exhibits 172: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 173: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 174: Veracyte Inc. - Overview
Exhibits 175: Veracyte Inc. - Product/Service
Exhibits 176: Veracyte Inc. - Key offerings
Exhibits 177: Inclusions checklist
Exhibits 178: Exclusions checklist
Exhibits 179: Currency conversion rates for US$
Exhibits 180: Research methodology
Exhibits 181: Validation techniques employed for market sizing
Exhibits 182: Information sources
Exhibits 183: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global oncology molecular diagnostics market: Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., MDXHEALTH SA, Myriad Genetics Inc., QIAGEN NV, QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., TBG Diagnostics Ltd., Thermo Fisher Scientific Inc., and Veracyte Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is integration of next-generation sequencing in oncology molecular diagnostics.'

According to the report, one of the major drivers for this market is the increasing prevalence of cancer worldwide.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
Agilent Technologies Inc.
Becton Dickinson and Co.
Biocartis NV
bioMerieux SA
Danaher Corp.
DiaSorin SpA
Exact Sciences Corp.
F. Hoffmann La Roche Ltd.
Grifols SA
Hologic Inc.
HTG Molecular Diagnostics Inc.
Illumina Inc.
MDXHEALTH SA
Myriad Genetics Inc.
QIAGEN NV
QuidelOrtho Corp.
Siemens Healthineers AG
Sysmex Corp.
TBG Diagnostics Ltd.
Thermo Fisher Scientific Inc.
Veracyte Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2417EUR$2,500USD£2,062GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3868EUR$4,000USD£3,300GBP

The oncology molecular diagnostics market is segmented as below:

By Product

By Type

By Geographical Landscape

The report on the oncology molecular diagnostics market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Global Molecular Diagnostics Market

Global Next Generation Sequencing Data Analysis Market 2023-2027

Oncology Molecular Diagnostics Market - Global Outlook & Forecast 2023-2028

Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027

Molecular Diagnostics